Adenine was discovered in 1885 by the German chemist Albrecht Kossel and was later introduced as a fundamental component of nucleic acids when the structure of DNA and RNA was elucidated in the 20th century. It became widely recognized for its role in genetic coding, pairing with thymine in DNA and uracil in RNA, and for its importance in energy-carrying molecules like ATP, making it essential in both genetics and cellular metabolism.
BRAND NAMES
Adenine itself is a naturally occurring nucleobase, so it does not have commercial brand names like drugs do. However, adenine is sometimes included as a component in nutritional supplements, biochemical reagents, or research products, but these are usually sold under the company or product name rather than as a distinct “brand” for adenine.
MECHANISM OF ACTION
Adenine is a purine nucleobase that functions as a building block for nucleotides like ATP, ADP, and AMP. It is essential for DNA and RNA synthesis, pairing with thymine in DNA and uracil in RNA to maintain genetic coding. Adenine-derived nucleotides also play key roles in energy transfer, cell signaling, and metabolism, making it vital for proper cellular function.
PHARMACOKINETICS
Absorption
Adenine, when taken orally or produced in the body, is absorbed through the small intestine into the bloodstream. It is transported into cells via nucleoside transporters and then metabolized into nucleotides such as AMP, ADP, and ATP, which the body uses for DNA/RNA synthesis and energy-related processes. Its absorption is generally efficient, but free adenine is rarely used as a drug; it is usually provided as part of nucleotides or nucleoside analogs.
Distribution
Adenine is distributed throughout the body via the bloodstream. It enters cells through nucleoside transporters and is primarily taken up by tissues with high rates of nucleic acid synthesis, such as the liver, bone marrow, and rapidly dividing cells. Inside cells, adenine is converted into nucleotides (AMP, ADP, ATP) and incorporated into DNA, RNA, or energy-carrying molecules, allowing it to participate in essential cellular functions.
Metabolism
Adenine is metabolized in the body through the purine salvage and degradation pathways. It is converted into AMP by adenine phosphoribosyltransferase for use in DNA, RNA, and ATP production. Excess adenine is broken down into hypoxanthine, then xanthine, and finally uric acid, which is excreted in the urine, allowing efficient recycling and removal of purines.
Elimination
Adenine and its metabolites are primarily eliminated through the urine. After being metabolized to uric acid via hypoxanthine and xanthine, uric acid is excreted by the kidneys. This renal excretion helps maintain purine balance in the body and prevents accumulation of excess adenine or its breakdown products.
PHARMACODYNAMICS
Adenine functions as a key purine nucleobase that influences cellular processes by serving as a precursor for nucleotides like AMP, ADP, and ATP. By incorporating into DNA and RNA, it ensures proper genetic coding and replication. Adenine-derived molecules also regulate energy transfer, signal transduction (e.g., cAMP), and enzymatic reactions, allowing it to control metabolic activity and maintain normal cellular function. Its effects are indirect, acting through its role in nucleotide synthesis and cellular energy dynamics.
ADMINISTRATION
Adenine is not typically administered as a standalone drug but can be supplied orally or intravenously as part of nucleotides, supplements, or research compounds. When given, it is absorbed via the gastrointestinal tract or directly into the bloodstream, then transported into cells for conversion into nucleotides like AMP, ADP, and ATP, supporting DNA/RNA synthesis and cellular energy processes.
DOSAGE AND STRENGTH
Adenine is generally not used as a conventional drug, so there is no standard therapeutic dosage or strength for humans. When used in research, supplements, or as part of nucleotide preparations, the amount varies depending on the purpose—typically in milligram (mg) quantities for experimental or nutritional use. Its administration is guided by cellular requirements for nucleotide synthesis rather than fixed dosing.
DRUG INTERACTIONS
Adenine rarely causes direct drug interactions, but when used in supplements or nucleotide preparations, it may interact with antimetabolites that affect purine metabolism, uric acid–lowering drugs like allopurinol, or medications that impact kidney function. These interactions mainly influence adenine’s metabolism and excretion rather than its direct activity in cells.
FOOD INTERACTIONS
Adenine itself has minimal direct interactions with food, as it is naturally present in many dietary sources like meat, fish, and legumes. However, a diet high in purines can increase adenine and uric acid levels in the body, potentially affecting its metabolism and excretion. Foods that promote uric acid buildup, such as organ meats and certain seafood, may influence how efficiently adenine is processed and eliminated.
CONTRAINDICATIONS
Adenine supplementation or therapy is generally contraindicated in people with gout, hyperuricemia, or severe kidney impairment, as it can lead to increased uric acid and reduced excretion. It should also be avoided in individuals with hypersensitivity to adenine-containing products to prevent adverse reactions.
SIDE EFFECTS
Adenine is usually well tolerated in the body as a natural nucleobase, but supplementation or high doses may cause mild side effects such as nausea, vomiting, or gastrointestinal discomfort. Excess adenine can increase uric acid levels, potentially leading to gout or kidney stones. Rarely, hypersensitivity reactions may occur with adenine-containing preparations.
TOXICITY
Excess adenine can be toxic, primarily due to its metabolism into uric acid, which may accumulate and cause hyperuricemia, gout, or kidney stones. Extremely high doses can also lead to renal dysfunction and impair nucleotide balance in cells. Toxic effects are rare under normal dietary intake but are a concern with high-dose supplements or experimental use.